CRYOPORT, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CRYOPORT, INC. stock issued during period, value, new issues for the quarter ending 2021-12-31 was $0.00.
- CRYOPORT, INC. stock issued during period, value, new issues for the quarter ending 2021-09-30 was $0.00.
- CRYOPORT, INC. stock issued during period, value, new issues for the quarter ending 2021-06-30 was $0.00.
- CRYOPORT, INC. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $269.82M.
- CRYOPORT, INC. stock issued during period, value, new issues for fiscal 2021 was $269.82M, a 13.74% increase from fiscal 2020.
- CRYOPORT, INC. stock issued during period, value, new issues for fiscal 2020 was $237.22M, a 244.75% increase from fiscal 2019.
- CRYOPORT, INC. stock issued during period, value, new issues for fiscal 2019 was $68.81M, a 601.55% increase from fiscal 2018.
- CRYOPORT, INC. stock issued during period, value, new issues for fiscal 2018 was $9.81M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $269.82M 10-K · filed 2024-03-13 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | |
| 2021-03-31 | $269.82M 10-Q · filed 2022-05-05 | |
| 2020-12-31 | $237.22M 10-K · filed 2021-03-01 | |
| 2019-12-31 | -$718.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $68.81M 10-K · filed 2021-03-01 |
| 2019-09-30 | $3.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | |
| 2019-06-30 | $68.81M 10-Q · filed 2020-08-10 | |
| 2018-12-31 | $9.81M 10-K · filed 2020-03-10 | |
| 2015-03-31 | $2.92M 10-K · filed 2016-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |